GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GeneFerm Biotechnology Co Ltd (ROCO:1796) » Definitions » Total Equity

GeneFerm Biotechnology Co (ROCO:1796) Total Equity : NT$796.1 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is GeneFerm Biotechnology Co Total Equity?

GeneFerm Biotechnology Co's total equity for the quarter that ended in Jun. 2024 was NT$796.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


GeneFerm Biotechnology Co Total Equity Historical Data

The historical data trend for GeneFerm Biotechnology Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneFerm Biotechnology Co Total Equity Chart

GeneFerm Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 389.72 396.19 747.66 830.77 892.84

GeneFerm Biotechnology Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 845.27 879.75 892.84 801.96 796.09

GeneFerm Biotechnology Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

GeneFerm Biotechnology Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1175.375-282.538
=892.8

GeneFerm Biotechnology Co's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=1238.667-442.573
=796.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GeneFerm Biotechnology Co Total Equity Related Terms

Thank you for viewing the detailed overview of GeneFerm Biotechnology Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneFerm Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 33, Xingong Road, Xinying District, Tainan, TWN, 74144
GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.

GeneFerm Biotechnology Co Headlines

No Headlines